Eating Against Yourself Part 3

Edited and approved by Stephen C. Rose, PhD, MS

The metabolic loop begins with mTORC1, a nutrient-sensing growth switch, being pushed toward the on position. Insulin resistance builds; the familiar markers of metabolic syndrome begin to appear. But a long-running metabolic problem does not stay neatly inside blood sugar and cholesterol panels. Over years, it reaches into the cell systems that make energy, clear damage, control inflammation, and mark biological aging. That broader connection is established in aging biology, although some of the specific cause-and-effect details in humans are still indirect or preliminary. [1]

The mitochondria: first casualty of the stuck switch

Mitochondria are often called the cell's power plants because they turn food-derived fuel into ATP, the energy currency cells spend to do work. But they are not little batteries that last forever. Healthy tissue constantly removes worn-out mitochondria through mitophagy, a recycling process, and makes new ones through mitochondrial biogenesis. When this turnover works, the cell keeps a fresher, cleaner energy fleet. When it slows, the cell is left with mitochondria that make less usable energy and leak more reactive oxygen species, which are chemically reactive molecules that can damage proteins, fats, and DNA.

This is where the aging language can sound scarier than it needs to. Oxidative stress does not mean oxygen is bad; it means the cell is producing more reactive byproducts than its antioxidant and repair systems can comfortably handle. Biogenesis does not mean the cell creates energy from nowhere; it means the cell builds new mitochondrial machinery. The established point is that mitochondrial dysfunction belongs on the short list of major aging mechanisms. [1] The more cautious point is that mitochondrial decline usually reflects many pressures acting together, not one switch acting alone.

Established mechanistic evidence shows that mTORC1 helps coordinate growth, protein production, metabolism, and autophagy, the broader cellular recycling system that includes mitophagy. [2] AMPK, by contrast, acts more like an energy-stress sensor. When cellular energy is low, AMPK helps shift the cell toward fuel burning and maintenance rather than constant growth. [3] The practical way to think about it is this: mTORC1 says "build," while AMPK says "check the fuel gauge and clean up." In a metabolically overfed, insulin-resistant state, the balance can drift toward building and away from cleanup. That is a plausible mechanism, not a complete human proof, for why metabolic dysfunction and mitochondrial dysfunction travel together.

The cell can end up with a fleet of damaged engines: still running, but running dirtier, slower, and with less capacity to replace themselves.

Human data make the mitochondrial story more than a theory, but the evidence should be labeled carefully. In the Study of Muscle, Mobility and Aging, older adults with better skeletal-muscle mitochondrial energetics had better leg power and cardiorespiratory fitness. [4] In the Baltimore Longitudinal Study of Aging, lower muscle mitochondrial oxidative capacity predicted later mobility decline in initially well-functioning older adults. [5] These are strong human associations and one longitudinal signal, but they do not prove that mTORC1 alone caused the decline. Aging, activity level, diet, illness, medications, and body composition all influence the same system.

Cellular senescence: the cells that refuse to die

Cellular senescence is another downstream effect worth understanding. A senescent cell is not dead. It is a damaged cell that has stopped dividing but continues to live, signal, and influence its neighbors. The basic observation that human cells can reach a limit in culture goes back to classic work by Hayflick and Moorhead. [6] In the body, senescence can be protective in the short term. If a cell has DNA damage, stopping it from dividing can reduce cancer risk. The problem begins when senescent cells accumulate faster than the immune system clears them.

Senescent cells release a mixture of inflammatory and tissue-remodeling signals called the senescence-associated secretory phenotype, or SASP. [7] Think of the SASP as a chemical broadcast. In a young, well-regulated tissue, that broadcast can help recruit immune cleanup. In older or metabolically stressed tissue, the broadcast can linger. Established and emerging evidence links the SASP with chronic inflammation, altered tissue structure, and the spread of senescence-like stress to nearby cells. [8] What remains uncertain is how much of this process can be reversed in ordinary humans by changing diet, exercise, or supplements. That is an active research question, not a settled clinical promise.

Inflammaging: when background noise becomes the signal

Inflammaging is the geroscience term for chronic, low-grade inflammation that rises with age. It is not the dramatic inflammation of an infected cut or a fever. It is quieter: a long-running increase in signals such as IL-6, TNF-alpha, CRP, and IL-1 beta. The established part is that chronic inflammation is one of the connected hallmarks of aging and is tied to many age-related diseases. [1,9] The more cautious part is assigning one single cause. Senescent cells, dysfunctional mitochondria, visceral fat, immune aging, poor sleep, inactivity, infections, and environmental stress can all feed the same inflammatory background.

This matters because inflammation does not just sit in the bloodstream. It changes how tissues behave. In muscle, inflammatory signaling can interfere with repair and contribute to the loss of strength and function. In fat tissue and liver, it can worsen insulin resistance. In blood vessels, it can push the lining of the artery toward a more irritated, less flexible state. That does not mean inflammation is always bad; the body needs acute inflammation to heal. The problem is chronic background activation, where the signal never fully shuts off.

The biological age clock: making damage measurable

For a long time, this kind of damage was hard to see directly. Standard lab tests measure things like glucose, kidney function, blood counts, and cholesterol. Those are useful, but they do not directly measure the pace of cellular aging. Epigenetic clocks changed the conversation. These clocks use DNA methylation, a chemical tagging pattern on DNA, to estimate biological age or the pace of aging from blood or tissue samples. [10] The established point is that these tools can estimate age-related biological patterns surprisingly well. The uncertain point is how best to use them for individual medical decisions.

DunedinPACE is especially useful for explaining the idea because it tries to estimate how fast a person's biology is aging now, not just how old their biology appears. [11] In the CALERIE randomized trial, two years of prescribed calorie restriction in adults without obesity produced small but measurable effects on DNA-methylation measures, including a slower DunedinPACE signal. [12] That is encouraging because it suggests the pace of aging may respond to environment and behavior. But the effect sizes were modest, and this does not mean everyone should restrict calories aggressively. It means the biology is movable.

Biological age is not a magic score. It is a measurement attempt, and like any measurement, it is most useful when interpreted with the rest of the clinical picture.

The bottom line is that a chronic metabolic loop can plausibly age tissue through several connected pathways: impaired mitochondrial maintenance, accumulated senescent cells, chronic low-grade inflammation, and measurable changes in biological-age markers. Some pieces are established, some are indirect, and some are still uncertain in humans. A later layer of the same story involves the thyroid axis, including why standard thyroid testing can miss important functional patterns and what a low-HDL pattern may be trying to tell you.